| Project/Area Number |
63571099
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
応用薬理学・医療系薬学
|
|---|
| Research Institution | School of Pharmaceutical Sciences, University of Shizuoka |
|---|
Principal Investigator |
YAMADA Shizuo School of Pharmaceutical Sciences, University of Shizuoka, Department of Biopharmacy, Assistant Professor, 薬学部, 講師 (80106434)
|
|---|
| Project Period (FY) |
1988 – 1989
|
| Project Status |
Completed (Fiscal Year 1989)
|
| Budget Amount *help |
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1989: ¥700,000 (Direct Cost: ¥700,000)
Fiscal Year 1988: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
|---|
| Keywords | Coronary artery / Ca^<++> antagonist receptor / Radioreceptor assay / [^3H]nitrendipine / (+)-[^3H]PN 200-110 / Divalent cations / EDTA / Non-dihydropyridine Ca^<++> antagonists / 冠動脈 / Ca拮抗薬受容体 / ^3H-ニトレソジピン / ^3H-PN200-110 / ^3H-ニトレンジピン / 受容体結合測定法 / ジルチアゼム / べラパミール |
|---|
| Research Abstract |
To identify and characterize the receptor sites for 1,4-dihydropyridine(DEP) Ca^<++> channel antagonists in coronary artery, we have measured specific binding of [^3H]nitrendipine(NTD) and (+)-[^3H]PN200-110(PN) in crude membranes of porcine coronary artery(PCA) by radioreceptor assay. Specific binding of [^3H]NTD and [^3H]PN in PCA was saturable, reversible and of high affinity, it showed a pharmacological specificity as well as stereoselectivity which characterized the receptor sites for DHP Ca^<++> antagonists. DHP antagonists(0.1+nM-1 muM) competed for the binding of both ligand in order:(+)PN> mepirodipine > nisoldipine > nicardipine > nitrendipine > nimodipine > nifedipine >(-)PN. (+)PN and mepirodipine exhibited 10 to 20 times greater affinity for [^3H]PN binding sites than nifedipine. (+)PN was approximately 140 times as potent as the (-)isomer. The potencies(pki) of these eight DHP Ca^<++> antagonists in competing for the ligand binding sites in PCA correlated well with their pharmacological potencies(pA_2)- Specific [^3H]PN binding in PCA was enhanced by d-cis-diltiazem and was inhibited incompletely by verapamil and D-600. Specific binding of [^3H]NTD and [^3H]PN was effectively inhibited by EDTA, and their Ki values were approximately 60 muM. In EDTA-pretreated PCA, the maximal number of binding sites(Bmax) for specific [^3H]PN binding was reduced(80 %) markedly, and it was restored to the untreated level by the addition of Ca^<++> and Mg^<++>. We conclude: 1) [^3H]NTD and [^3H]PN selectively label the pharmacological relevant DHP Ca^<++> antagonist receptors in PCA; 2) d-cis-diltiazem and verapamil are allosteric modulators of DHP receptor sites in the vascular tissues; 3) the binding of DHP antagonists to the vascular receptors is an extremely dependent process of the presence of divalent cations.
|
